jan 1, 2021 - The creation of the COVID-19 vaccine aided by Kizzmekia Corbett

Description:

In response to the ongoing global COVID-19 pandemic, Corbett's team designed the vaccine concept incorporated in mRNA-1273 from viral sequence data and rapidly deployed it to industry partner Moderna, Inc. for a U.S. Food and Drug Administration (FDA)-approved Phase 1 clinical trial, which began only 66 days after the viral sequence release. COVID-19 vaccination

https://asm.org/Biographies/Kizzmekia-S-Corbett,-Ph-D

Added to timeline:

Date:

Images: